In patients with multiple myeloma (MM) eligible for autologous stem cell (SC) transplant (SCT), SC are mobilized in peripheral blood for subsequent collection using granulocyte colony-stimulating factor (G-CSF) alone [1] or following chemotherapy with cyclophosphamide [1–4]. This evidence concerns the gene CSF3 and AL amyloidosis.